iFAST Diagnostics
It has developed a test delivering results in under three hours from a positive blood bottle or 3 to 4 hours from a raw urine sample, saving lives and reducing the spread of antimicrobial resistance.
iFAST Diagnostics has raised €5.8M across 1 funding round from 7 investors, most recently a round in May 2026. Based in London, UK; active in Healthtech. Data as of 28 Oct 2026.
London, UKifastdiagnostics.com ↗
Total raised
€5.8M
€5,772,468
Funding rounds
1
Investors
7
distinct backers
Active since
2026-05
latest 2026-05
Funding by year
EUR raised per year · 2026 YTDiFAST Diagnostics — funding by year — interactive chart.
Data table
| iFAST Diagnostics — funding by year | |
|---|---|
| 2026 | €5.8M |
Signals
High confidenceRaise-next likelihood22
base rate 30% for Other
- ▼ Raised very recently
- ▼ Low backer re-investment
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-05-27 | Other | €5.8M | Qantx,existing subscribers,Innovate UK grant,members of Cambridge Capital Group,Meridian Health Ventures (MHV),OKG Capital+1 more | View deal → |